Article
The importance of CYP2C19 genotype in tacrolimus dose optimization when concomitant with voriconazole in heart transplant recipients.
British journal of clinical pharmacology - 1 Oct 2022
Huang Xiao, Zhou Ying, Zhang Jing, Xiang Hongping, Mei Hao, Liu Li, Tong Lu, Zeng Fang, Huang Yifei, Zhou Hong, Zhang Yu
Abstract excerpt
AIMS: Voriconazole remains the mainstay for the treatment of invasive fungal infections in heart transplant patients and can significantly increase tacrolimus exposure because of drug-drug interaction (DDI). However, the magnitude of this DDI is highly variable and difficult to predict. The purpose of this study was to present the characteristics of the DDI between tacrolimus and voriconazole, and further...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
